The Venture Codex Logo

The Venture Codex

E1 Ventures

535 Mission St, San Francisco, CA, 94105, United States

Overview

E1 Ventures is a systematic venture capital firm based in Silicon Valley. As a stage-agnostic fund, we implement proprietary algorithms, data science, and extensive datasets to pinpoint prime investment opportunities, particularly in deep tech. Our proprietary platform, E/Quant, employs machine learning, advanced natural language processing, statistical modeling, and both predictive and semantic analysis for thorough data evaluation. E/acc.

Total investments
2
Lead investments
1
Investments · 12mo
0
Active investors
1

Sector focus

  • Finance
  • Venture Capital
Visit website

Investment portfolio

  • Phantom Neuro

    Participated · Series A · Apr 2025

    Phantom Neuro develops a minimally invasive neural interface platform called Phantom X to enable intuitive control of prosthetic limbs and robotic exoskeletons. Phantom X, originally developed at the Johns Hopkins University School of Medicine, is designed to restore natural movement by making assistive devices function as seamless extensions of the body. The company reported that its ASCENT study demonstrated 94% accuracy decoding real-time gestures across 11 essential hand and wrist movements. Phantom Neuro has received FDA Breakthrough Device and TAP designations for Phantom X, which may expedite regulatory approvals. The company plans to use new funding to accelerate preclinical testing, complete first-in-human trials, pursue regulatory submissions, and expand R&D for broader control applications beyond prosthetic limbs. Phantom Neuro is headquartered in Austin, Texas and has raised $28 million in total funding to date. Phantom Neuro develops a low-power, high-accuracy system intended to provide lifelike control of robotic orthopedic technologies. The company is positioned in the neurotech sector and is based in Austin, TX. Its core product targets control interfaces for robotic orthopedics, emphasizing low power consumption and high accuracy. The article does not disclose operating metrics such as revenue or user counts. Phantom Neuro announced a $6 million expanded seed financing, which increases its total funding to $9.5 million. The funding supports the company’s continued development of its control system for robotic orthopedic applications. Phantom Neuro is a neurotechnology company based in Austin, Texas and Baltimore, Maryland that is creating a system to enable lifelike control of robotic orthopedic technologies such as prosthetic limbs and exoskeletons. Its solution combines low-risk implantable sensors, AI, and enabling software to provide control of existing and next-generation orthopedic devices. The company is led by founder and CEO Dr. Connor Glass. Phantom Neuro raised seed funding to expand its operations and business reach. The $3.26M round was led by LionBird Ventures with participation from Draper Associates, Breakout Ventures, Blackrock Neurotech, Capital Factory, and private investors. As part of the financing, LionBird partner Robert Lord will join the board and LionBird Managing Partner Ed Michael will join as a board observer.

  • DwellFi

    Led · Seed · May 2024

    DwellFi offers a SOC‑2 certified SaaS platform that combines AI, blockchain, and tokenization to support asset management for private funds and fund administrators. The platform is designed for enterprise clients and adapts to market needs. DwellFi reports over $200B in assets under administration (AUA). The company has raised $3M in Seed funding to date. It plans to use the funds to expand operations and development efforts. DwellFi is led by CEO Kumar Ujjwal and CTO Deepak Sheoran.

Team